Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine and postoperative sleep after ambulatory laparoscopic cholecystectomy
ChiCTR2400089861Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Postoperative sleep disturbance (PSD) comparing Esketamine 0.3 mg/kg/h infusion with Normal saline infusion (placebo) (2 arms). Primary endpoint: Athens Insomnia Scale score postoperative day 1. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2400089861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089861.